In this week's podcast episode, we feature Ancora.ai, a company connecting cancer patients with clinical trials and empowering them to understand ongoing trial options.
Ancora.ai maintains a research database of all ongoing cancer trials, including neuroendocrine cancer, making it easier for patients to find personalised trial options. The podcast with CEO and founder, Danielle Ralic, explores the challenges of finding relevant clinical trials and how Ancora.ai helps overcome them. Listeners will learn about the company's serendipitous origin and the opportunities it offers for patients to understand and discuss clinical trials with their medical teams. Ancora.ai is easy to use, fast, and free, making it a valuable resource for cancer patients seeking innovative treatments.
Useful links: